Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis

Background Allergen immunotherapy (AIT) is effective in patient with local allergic rhinitis (LAR). However, AIT may not always achieve the optimal treatment effect. Objective To present short study with clinical cases of LAR combined therapy with sublingual immunotherapy (SLIT) and omalizumab in pa...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Andrzej Bozek, Renata Kozłowska, Maciej Misiołek, Wojciech Ścierski, Radosław Gawlik
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Taylor & Francis Group 2022-11-01
Serie:	Human Vaccines & Immunotherapeutics
Ämnen:	local allergic rhinitis omalizumab allergen immunotherapy
Länkar:	http://dx.doi.org/10.1080/21645515.2022.2097818
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!